Ex-Takeda Exec Settles SEC Insider Trading Claims
A former Takeda Pharmaceuticals International Inc. executive agreed Thursday to pay $136,000 to settle a U.S. Securities and Exchange Commission suit alleging he profited from insider trading before a major Takeda...To view the full article, register now.
Already a subscriber? Click here to view full article